Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-09-04
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participation in this study consists of one study visit for healthy volunteers, but will last up to six months for Duke Patients. At each standard of care clinic visit throughout six months, Duke Patients will be asked to also come in for a study visit, wear the EMG shorts, and perform the same exercises preformed during the first study visit.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Conservative Intervention of Femoroacetabular Impingement Syndrome
NCT02706756
Diagnosis and Treatment of Patients With Femoroacetabular Impingement Syndrome
NCT03846817
Fulfillment of Expectations for Patients With FAI Syndrome
NCT03278353
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
NCT03261544
Clinical and Functional Outcomes at Least 2 Years After Hamstring Muscle Repair
NCT04867746
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with Hip Pain or Injuries
Electromyopathy (EMG) Shorts
Participants will be asked to complete physical activities while wearing EMG shorts
Healthy Participants
Electromyopathy (EMG) Shorts
Participants will be asked to complete physical activities while wearing EMG shorts
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electromyopathy (EMG) Shorts
Participants will be asked to complete physical activities while wearing EMG shorts
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All subjects must be 18 years of age or older.
* Any patient that currently has hip pain or injury and is seeking treatment from either Dr. Mather, Dr. Lewis, or Dr. Olson, within the hip preservation clinics.
* Subjects must be able to fit into the shorts in order to participate.
Inclusion (Healthy Volunteers):
* All healthy volunteer subjects must be 18 years of age or older.
* Subjects must be able to fit into the shorts in order to participate.
Exclusion Criteria
* Any recent lower extremity injury (such as an ankle sprain/surgery or knee surgery).
* Patient is unable to provide written consent, or patient is unable to speak, write, or understand English.
* Pregnant women (Verbal Confirmation)
* Allergic or hypersensitivity to laminate material.
Exclusion (Healthy Volunteers):
* Any recent lower extremity injury (such as an ankle sprain/surgery or knee surgery).
* Prior hip surgery, or current hip injury, surgery, or pain.
* Patient is unable to provide written consent, or patient is unable to speak, write, or understand English.
* Pregnant women (Verbal Confirmation)
* Allergic or hypersensitivity to laminate material.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Mather, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00104994
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.